Fulgent Genetics Inc (FLGT) Annual Balance Sheets

Annual · GAAP · USD millions
Access FLGT quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Fulgent Genetics Inc's financial stability and long-term positioning.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent50.19
Available-for-sale Securities, Debt Securities, Current MA285.88
Cash & Short-term Investments335.00
Accounts receivable84.76
Other Current Assets22.55
Prepaid Taxes PR107.10
Total Current Assets550.49
Equipment/Property/Plant Net112.55
Goodwill net25.08
Intangible Assets68.49
Long-term investments369.27
Other Assets, Noncurrent456.92
Available For Sale Securities Debt Equity Securities And Trading Securities Current-
Total Assets1,213.53
Liabilities
Accounts Payable, Current AC18.65
Accrued Liabilities, Current AC34.06
Notes Payable, Current NO0.48
Other Liabilities, Current24.50
Unrecognized Tax Benefits7.28
Business Combination, Contingent Consideration, Liability, Current BU0.00
Total Current Liabilities84.97
Total Long-term Debt0.00
Other liabilities, Noncurrent21.84
Deferred Income Tax Liabilities Net6.94
Customer Deposit28.15
Investment Margin Liabilities Current-
Total Liabilities106.81
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock574.52
Retained Earnings / Accumulated Deficit529.95
Other Equity7.51
Common Stockholder's Equity1,111.99
Non-controlling interests & other-5.27
Total Stockholder's Equity1,106.72
Liabilities & Stockholder's Equity1,213.53
4 historic quarters locked

Sign in to unlock the full Fulgent Genetics Inc balance sheet history.

About Fulgent Genetics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 27, 2026
  • Source: flgt-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-079169

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License